Quote | Zentalis Pharmaceuticals Inc. (NASDAQ:ZNTL)
Last: | $11.31 |
---|---|
Change Percent: | -0.45% |
Open: | $11.11 |
Close: | $11.31 |
High: | $11.97 |
Low: | $10.82 |
Volume: | 1,017,297 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
News | Zentalis Pharmaceuticals Inc. (NASDAQ:ZNTL)
2024-04-12 14:12:23 ET Summary Zentalis Pharmaceuticals, Inc. expects final results from phase 1b study, using azenosertib + gemcitabine for the treatment of patients with osteosarcoma, in the 1st half of 2024. In a phase 1 study, using monotherapy azenosertib for 19 patients with...
2024-04-11 07:33:18 ET More on Zentalis Pharmaceuticals Zentalis Pharmaceuticals: Azenosertib Continues To Impress Zentalis: Leading WEE1 Developer After AstraZeneca's Exit Read the full article on Seeking Alpha For further details see: Zentalis Pharmaceu...
Message Board Posts | Zentalis Pharmaceuticals Inc. (NASDAQ:ZNTL)
Subject | By | Source | When |
---|---|---|---|
We managed to get a new 26 week | ANTADOG | investorshub | 07/04/2020 6:31:24 PM |
Added some 46's , nice chart reset, ANT | ANTADOG | investorshub | 06/30/2020 8:24:03 PM |
55.12~~ looks like this puppy is on it's | ANTADOG | investorshub | 06/25/2020 2:26:00 PM |
NEW YORK and SAN DIEGO, June 15, 2020 | ANTADOG | investorshub | 06/19/2020 9:34:03 PM |
NEW YORK and SAN DIEGO, May 28, 2020 | ANTADOG | investorshub | 05/30/2020 9:44:18 AM |
News, Short Squeeze, Breakout and More Instantly...
Zentalis Pharmaceuticals Inc. Company Name:
ZNTL Stock Symbol:
NASDAQ Market:
NEW YORK and SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutica...
NEW YORK and SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, wi...
2024-03-27 00:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...